man MS, Baron AD. Effects of exenatide(exendin-4) on glycemic control over 30weeks in sulfonylurea-treated patientswith type 2 diabetes. Diabetes Care 2004;27:2628–2635 10. DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of ex-enatide (exendin-4) on glycemic controland weight over 30 weeks in metformin-treated patients with type 2 diabetes. Di-abetes Care 2005;28:1092–1100 11. Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, BaronAD. Effects of exenatide (exendin-4) onglycemic control over 30 weeks in pa-tients with type 2 diabetes treated withmetformin and a sulfonylurea. DiabetesCare 2005;28:1083–1091 12. Zinman B, Hoogwerf BJ, Dura ´n García S, Milton DR, Giaconia JM, Kim DD, Traut-mann ME, Brodows RG. The effect of add-ing exenatide to a thiazolidinedione insuboptimally controlled type 2 diabetes: arandomized trial. Ann Intern Med 2007;146:477–485 13. Barnett AH, Burger J, Johns D, Brodows R,